Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Net Income (2016 - 2025)

Palisade Bio has reported Net Income over the past 16 years, most recently at -$10.0 million for Q4 2025.

  • Quarterly Net Income fell 194.92% to -$10.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.1 million through Dec 2025, down 21.48% year-over-year, with the annual reading at -$18.1 million for FY2025, 21.48% down from the prior year.
  • Net Income was -$10.0 million for Q4 2025 at Palisade Bio, down from -$2.9 million in the prior quarter.
  • Over five years, Net Income peaked at -$2.3 million in Q1 2025 and troughed at -$33.5 million in Q2 2021.
  • The 5-year median for Net Income is -$3.6 million (2023), against an average of -$5.4 million.
  • Year-over-year, Net Income plummeted 1718.88% in 2021 and then skyrocketed 89.33% in 2022.
  • A 5-year view of Net Income shows it stood at -$3.0 million in 2021, then fell by 26.59% to -$3.9 million in 2022, then grew by 18.0% to -$3.2 million in 2023, then dropped by 7.19% to -$3.4 million in 2024, then crashed by 194.92% to -$10.0 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Net Income are -$10.0 million (Q4 2025), -$2.9 million (Q3 2025), and -$2.8 million (Q2 2025).